Who makes ARS-1 without URTI?

ARS-1 without URTI is developed by ARS Pharmaceuticals, Inc..

What development phase is ARS-1 without URTI in?

ARS-1 without URTI is in Phase 1.

Last reviewed 2026-04-23 · How we verify

ARS-1 without URTI

ARS Pharmaceuticals, Inc. · Phase 1 active Small molecule

At a glance

Generic name	ARS-1 without URTI
Sponsor	ARS Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ARS-1 without URTI CI brief — competitive landscape report
ARS-1 without URTI updates RSS · CI watch RSS
ARS Pharmaceuticals, Inc. portfolio CI